While some of these mutations have been observed previously in the context of ALK-fusion cancers, we characterize two novel mutations that thus far have only been observed in neuroblastoma – T1151M and R1192P – and two mutations not previously characterized in ALK+ ALCL (Table 1). This evidence concerns the gene ALK and cancer.